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Abstract:		Cerebrovascular	pressure	autoregulation	is	the	physiologic	mechanism	that	holds	cerebral	blood	flow	(CBF)	relatively	constant	across	changes	in	cerebral	perfusion	pressure	(CPP).	Cerebral	vasoreactivity	refers	to	the	vasoconstriction	and	vasodilation	that	occur	during	fluctuations	in	arterial	blood	pressure	(ABP)	to	maintain	autoregulation.	These	are	vital	protective	mechanisms	of	the	brain.	Impairments	in	pressure	autoregulation	increase	the	risk	of	brain	injury	and	persistent	neurologic	disability.	Autoregulation	may	be	impaired	during	various	neonatal	disease	states	including	prematurity,	hypoxic-ischemic	encephalopathy	(HIE),	intraventricular	hemorrhage,	congenital	cardiac	disease,	and	infants	requiring	extracorporeal	membrane	oxygenation	(ECMO).	Because	infants	are	exquisitely	sensitive	to	changes	in	cerebral	blood	flow	(CBF),	both	hypoperfusion	or	hyperperfusion	can	cause	significant	neurologic	injury.	We	will	review	neonatal	pressure	autoregulation	and	autoregulation	monitoring	techniques	with	a	focus	on	brain	protection.	Current	clinical	therapies	have	failed	to	fully	prevent	permanent	brain	injuries	in	neonates.	Adjuvant	treatments	that	support	and	optimize	autoregulation	may	improve	neurologic	outcomes.	
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Unique	features	of	infant	cerebral	physiology	
CBF	regulation	in	the	premature	and	term	infant’s	brain	is	distinct	from	that	of	the	fully	matured	brain.	Term	infants	have	functional	autoregulation	and	vasoreactivity.	Preterm	infants,	especially	those	born	at	the	limits	of	viability,	have	anatomically	incomplete	and	underdeveloped	cerebral	vasculature	that	cannot	yet	autoregulate	fully.		Studies	in	preterm	lambs	suggest	that	the	cerebral	artery	and	arteriole	muscularis	layers	develop	after	13	weeks’	gestation,	which	is	equivalent	to	approximately	25	weeks’	of	human	gestation.	Autoregulation	is	functional	by	19	weeks’	gestation	in	lambs,	which	is	approximately	36	weeks’	of	human	gestation.1	In	clinical	studies	of	premature	neonates,	autoregulatory	function	progressively	improves	between	23	and	33	weeks	gestation.2	Therefore,	the	vasoreactive	mechanisms	that	support	autoregulation	develop	during	the	third	trimester,	which	has	implications	for	many	infants	who	are	born	prematurely.	
	In	addition	to	the	on-going	vascular	development,	anatomical	features	of	the	premature	cerebral	vasculature	may	place	the	premature	infant	at-risk	for	injury.	Preterm	neonates	have	fragile	periventricular	vascular	overgrowth	in	the	germinal	matrix	that	is	prone	to	hemorrhage.	White	matter	vascularization	from	penetrating	pial	arterial	growth	and	collateral	vascularization	are	also	incomplete.	Moreover,	the	newborn’s	subarachnoid	space	contains	a	network	of	thin-walled	vessels.	These	fragile	and	under-developed	vascular	networks	place	these	infants	at	high	risk	of	germinal	matrix	and	subarachnoid	hemorrhages,	periventricular	leukomalacia,	leukoencephalopathy,	corpus	callosum	gliosis	and	multi-cystic	encephalopathy.3		
These	unique	aspects	of	preterm	cerebral	vasculature	and	anatomy	are	accompanied	by	gross	differences	in	CBF	between	preterm	and	term	neonates.	CBF	increases	progressively	during	fetal	life	and	infancy,	peaking	in	the	pre-teen	years	and	then	declines	steadily	into	adulthood.	The	infant	brain	
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consumes	17%	of	cardiac	output	and	accounts	for	17%	of	the	body	mass.	In	comparison,	the	adult	brain	comprises	just	over	2%	of	total	body	mass	but	utilizes	25%	of	the	cardiac	output.	Low	placental	vascular	resistance	and	low	arterial	oxygen	content	of	fetal	blood	both	influence	fetal	CBF.	After	birth,	CBF	increases	during	the	first	day	of	life	due	to	decreasing	cerebrovascular	resistance	and	then	CBF	continues	to	gradually	increase	over	the	first	week	of	life.4	However,	CBF	in	many	infants	hovers	near	the	ischemic	threshold	of	20	cc/100g/min.	In	healthy	term	and	pre-term	infants	without	respiratory	distress	syndrome,	CBF	at	birth	is	roughly	one-third	of	adult	values.5-8	Rapid	postnatal	brain	development	then	causes	cerebral	glucose	consumption	and	blood	flow	to	rapidly	increase	after	birth	and	peak	at	approximately	5	years	of	age.9,10	
Finally,	the	preterm	neonate	with	hypotension	can	have	CBF	that	is	more	influenced	by	cardiac	cycle	changes	than	term	neonates.	Premature	neonates	have	very	low	blood	pressure	compared	to	term	neonates.	During	diastole	in	a	hypotensive	preterm	neonate,	CBF	is	passive	to	diastolic	blood	pressure,	and	often	absent	entirely.	CBF	autoregulation,	when	it	occurs	in	this	population,	is	most	robust	and	present	during	the	systolic	phase	cardiac	cycle	compared	to	CBF	autoregulation	of	the	mean	and	diastolic	phases	of	the	cardiac	cycle.	Further,	pressure	reactivity	and	autoregulation	to	systolic	and	mean	ABP	is	not	observed	until	26	to	28	weeks’	gestation.2		
	
Neonatal	arterial	blood	pressure	management	
Hypotension	with	low	CBF	and	post-ischemia	reperfusion	contribute	to	the	pathogenesis	of	brain	injury	in	human	prematurity,11-14	HIE,	and	experimental	animal	models.15-20	Hypoperfusion,	reperfusion	and	hyperemia	may	promote	neural	injury	through	a	variety	of	mechanisms	that	include	oxygen-glucose	deprivation,	endoplasmic	reticulum	stress,	disruptions	in	proteostasis,	glutamate	excitotoxicity,	oxidative	
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stress,	inflammation	and	ultimately	activation	of	cell	death	pathways	in	gray	and	white	matter.21-27	Ensuring	appropriate	CBF	to	the	injured	neonatal	brain	could	block	these	injurious	mechanisms	and	minimize	secondary	brain	injury.	
	ABP	is	the	most	frequently	monitored	parameter	to	assess	hemodynamic	status	in	infants.	However,	ABP	does	not	correlate	to	systemic	blood	flow	as	shock	can	occur	during	normotension.28,29	While	the	goal	of	neonatal	ABP	management	is	to	adequately	perfuse	the	brain	and	other	vital	organs,	evidence-based	ABP	thresholds	that	define	hypotension	with	cerebral	hypoperfusion	do	not	exist.	Moreover,	we	do	not	know	whether	we	should	support	ABP	with	vasopressors,	inotropes,	or	fluid	resuscitation	and	when	to	initiate	these	treatments.	Defining	optimal	neonatal	ABP	management	to	support	cerebral	and	other	vital	organ	perfusion	would	significantly	advance	clinical	care.30-34		
Multiple	observational	cohort	studies	report	“normative”	ABP	ranges	based	on	birth	weight,	gestational	age	(GA),	and	postnatal	age.35-40	Many	neonatologists	define	hypotension	on	the	first	day	of	life	as	mean	ABP	less	than	or	equal	to	the	GA	in	weeks.41		However,	outcomes	are	similar	between	neonates	with	mean	ABP	less	than	GA	and	those	with	normal	blood	pressure	when	perfusion	is	clinically	adequate.42,43	The	paucity	of	evidence	showing	improved	outcomes	after	raising	ABP	to	a	“normal	range”	has	prevented	neonatologists	from	defining	hypotension	and	setting	ABP	treatment	thresholds.	In	fact,	treating	hypotension	may	be	deleterious	and	could	increase	the	risk	of	intraventricular	hemorrhage.42,44	
	
Cerebrovascular	pressure	autoregulation	curves	vary	among	individual	neonates	
Cerebrovascular	pressure	autoregulation	protects	the	brain	from	deleterious	CBF	fluctuations	in	the	face	of	changing	CPP.	The	classic	mechanistic	depiction	is	a	sigmoidal	curve	with	stable	CBF	across	a	range	of	CPP	and	pressure	passive	CBF	outside	this	range.	(Figure	1)	The	range	of	functional	
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autoregulation,	which	is	called	the	autoregulatory	plateau,	is	bounded	by	the	upper	limit	of	autoregulation	(ULA)	and	the	lower	limit	of	autoregulation	(LLA).	Cerebral	vasoreactivity	functions	only	when	CPP	is	along	this	plateau.	Above	the	ULA	and	below	the	LLA,	CBF	is	passive	to	blood	pressure	due	to	impaired	vasoreactivity	and	the	brain	is	at	risk	of	hyperemic	or	hypoperfusion	injury.		
The	optimal	ABP	and	CPP	are	conceptually	located	in	the	center	of	the	autoregulatory	plateau	and	represent	the	pressures	at	which	vasoreactive	responses	are	most	robust.	Optimizing	ABP	and	CPP	to	maximize	vasoreactivity	may	reduce	the	risk	of	secondary	brain	injury.	Because	neonatal	intracranial	pressure	(ICP)	monitoring	is	generally	not	feasible,	neonatologists	must	rely	upon	ABP	management	to	support	autoregulation.	
Pressure	autoregulation	is	one	of	many	cerebral	servomechanisms	that	regulate	CBF.	Other	mechanisms	include	neurovascular	coupling;	the	systemic	vasoconstrictive	response	to	shock	with	activation	of	the	sympathetic	nervous	system,	renin-angiotensin-aldosterone	axis,	and	vasopression	release;	and	cerebral	vasoreactivity	to	carbon	dioxide,	oxygen,	and	glucose.	45-49	Pressure	autoregulation	can	be	measured	independent	of	these	other	CBF	regulators	by	collecting	ABP	and	cerebral	waveform	data	at	the	frequency	of	0.004-0.05	Hz	(20-250	seconds).	This	frequency	is	where	slow	wave	changes	in	CBV	occur	during	pressure	autoregulatory	vasoreactivity.50	
Autoregulation	can	be	characterized	by	static,	or	dynamic	metrics.	Static	autoregulation	describes	the	steady	state	changes	of	cerebrovascular	resistance	when	ABP	varies,	and	dynamic	autoregulation	metrics	describe	changes	in	cerebrovascular	resistance	and	flow	in	a	faster	time	course.	The	results	of	these	methods	are	related,	but	not	necessarily	interchangeable,	and	there	is	no	gold	standard	measure	of	autoregulation.	Autoregulation	metrics	must	capture	a	change	in	ABP	alongside	a	synchronous	measurement	of	CBF,	cerebral	blood	volume	(CBV),	or	cerebral	oxygenation.	The	relationship	between	
	 8	
the	change	in	ABP	and	change	in	CBF,	CBV,	or	oxygenation	is	mathematically	estimated	to	provide	an	index	of	autoregulatory	function.	Vasoreactivity	is	measured	by	changes	in	CBV.	Autoregulation	is	measured	by	changes	in	CBF	or	oxygenation.		
	Pressure	autoregulation	monitoring	can	define	an	individual	patient’s	unique	cerebral	autoregulation	and	vasoreactivity	physiology	to	determine	the	optimal	ABP	with	most	functional	autoregulation	in	addition	to	the	ULA	and	LLA.	This	could	enable	patient-oriented,	neonatal	precision	medicine	that	is	superior	to	generalized	ABP	goals	based	on	gestational	age	or	body	weight.	
An	individual	infant’s	LLA,	optimal	ABP,	ULA,	and	autoregulatory	plateau	may	shift	during	evolving	brain	injury	and	treatment.	In	a	piglet	model	of	hydrocephalus,	the	LLA	shifted	to	a	higher	CPP	during	progressive	intracranial	hypertension	from	artificial	cerebrospinal	fluid	infusion	or	from	cephalic	venous	outflow	obstruction	with	intracranial	venous	congestion.51,52	Additional	analysis	from	the	piglet	hydrocephalus	data	showed	that	optimal	ABP	increases	with	rising	ICP.	Intracranial	hypertension	can	also	move	the	ULA	to	a	lower	CPP.53	The	combination	of	an	increased	LLA	(rightward	shift)	and	a	decreased	ULA	(leftward	shift)	causes	the	autoregulatory	plateau	to	narrow.	Whole-body	hypothermia	after	neonatal	brain	hypoxia	acutely	decreases	the	LLA,	although	this	LLA	shift	was	not	sustained	with	longer	durations	of	hypothermia.54,55	Further,	autoregulatory	responses	to	different	vasopressors	may	vary	by	sex	and	age	after	brain	injury.33,56-59	Milrinone	may	significantly	decrease	blood	pressure	to	below	optimal	ABP	in	girls.33	Common	neonatal	clinical	situations	with	the	potential	physiologic	changes	outlined	above	include	progressive	intracranial	hypertension	with	hydrocephalus,	cerebral	venous	outflow	impediments	with	cavo-pulmonary	shunts	for	cardiac	anomalies,	high	ventilator	airway	pressures,	therapeutic	hypothermia	for	HIE,	extracorporeal	membrane	oxygenation	(ECMO),	and	vasopressor	and	afterload	reduction	therapies.		
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Critical	Closing	Pressure	
	 The	critical	closing	pressure	(CrCP)	is	a	crucial	component	of	neonatal	cerebrovascular	physiology	that	remains	relatively	understudied.	The	CrCP	is	the	ABP	at	which	CBF	ceases	due	to	vascular	collapse.	It	is	posited	to	be	the	sum	of	vascular	wall	tension	and	ICP.60	CrCP	normalizes	the	ABP	to	an	“effective	CPP”	or	“closing	margin”	where	the	effective	CPP	=	ABP	–	CrCP.61,62	In	premature	neonates,	low	diastolic	blood	pressures	can	approach	or	reach	the	CrCP	with	little	evident	CBF.2,63	The	CrCP	in	HIE	and	other	neonatal	neurologic	diseases	deserves	further	study.	CrCP	is	distinct	from	and	lower	than	the	autoregulatory	plateau.	When	ABP	is	below	the	lower	limit	of	autoregulation,	CBF	is	passive	to	ABP.	When	ABP	is	below	the	CrCP,	CBF	ceases	altogether.	The	low	diastolic	blood	pressure	of	the	preterm	neonate	results	in	a	CBF	pattern	that	can	occur	only	during	systole	as	ABP	cycles	above	and	below	CrCP	with	each	cardiac	cycle.	Intuitively,	one	might	hypothesize	that	this	state	is	a	vulnerability	to	ischemia	and	white	matter	injury,	but	these	associations	have	not	yet	been	studied	as	the	tools	to	measure	CrCP	are	relatively	new.	
The	CrCP	increases	gradually	from	23	to	31	weeks’	gestation	at	a	rate	of	1.4	mm	Hg	per	week	and	is	approximately	22-33	mm	Hg	in	premature	and	term	infants.63-65	Intersubject	variability	in	the	CrCP	was	high	in	that	study,	suggesting	that	CrCP	cannot	be	estimated	by	age,	but	requires	direct	measurement	(Figure	2).	The	time	courses	of	CrCP	changes	during	transition	to	extrauterine	life,	and	during	common	comorbid	conditions	have	not	yet	been	elucidated.	Small	variances	in	CrCP	cause	large	variances	in	effective	CPP	in	preterm	infants.		For	example,	a	10	mm	Hg	increase	in	CrCP	from	20	to	30	mm	Hg	would	profoundly	decrease	CBF	in	a	preterm	infant	with	a	mean	ABP	of	30	mm	Hg	because	the	effective	CPP	would	change	from	10	mm	Hg	to	zero.	An	identical	10	mm	Hg	CrCP	increase	would	have	trivial	effect	on	CBF	in	an	adult	with	a	mean	ABP	of	70	mm	Hg.		
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The	proximity	of	ABP	to	CrCP	in	preterm	infants	may	make	CrCP	an	effective	cerebral	perfusion	metric	in	this	population.	Simply	stated,	the	ABP	and	CrCP-derived	effective	CPP	may	be	more	relevant	to	define	brain	perfusion	in	preterm	neonates	than	ABP	alone.	Therefore,	autoregulation	monitoring	in	these	infants	should	take	into	account	CrCP	and	the	effective	CPP.	Further,	in	very	preterm	neonates	who	may	lack	autoregulatory	capacity	entirely,	the	CrCP	measurement	may	provide	an	alternate	therapeutic	target	to	manage	cerebral	hemodynamics	in	an	“adequate	but	not	hyperemic”	range	that	has	yet	to	be	elucidated	by	wider	study	of	this	parameter	in	this	population.	
	
Non-invasive	autoregulation	and	vasoreactivity	monitoring	in	neonates	
ICP	monitoring	is	frequently	used	to	measure	changes	in	CBV	during	cerebral	vasoreactivity	in	adults	and	children.	Because	invasive	cranial	monitors	are	not	routinely	used	in	neonatal	clinical	practice,	non-invasive	autoregulation	metrics	have	been	developed	and	applied	to	neonates.	All	non-invasive	autoregulation	metrics	are	limited	by	anatomic	region.	For	instance,	dysfunctional	autoregulation	in	cerebellum	will	not	be	detected	by	measures	in	the	frontal	cortex	or	in	a	single	cortical	cerebral	artery.1		
Historically,	neonatal	cerebral	autoregulation	has	been	monitored	most	frequently	with	transcranial	Doppler	(TCD)	ultrasound	to	measure	CBF-velocity	in	a	target	artery,	such	as	the	middle	or	anterior	cerebral	artery.2,66-70	Prior	to	this	technique,	measurement	of	CBF	in	human	subjects	relied	on	indicator-dilution	techniques.	TCD	allows	for	non-invasive	estimates	of	CBF	velocity	and	can	easily	be	performed	at	the	bedside.	However,	TCD	has	its	limitations.	It	is	only	capable	of	measuring	velocity	and	not	flow,	and	there	are	technical	challenges	of	obtaining	a	stable	long-term	signal	in	very	preterm	infants.	
Near-infrared	spectroscopy	(NIRS)	has	been	widely	used	to	study	neonatal	cerebral	hemodynamics	and	oxygenation;	NIRS	takes	advantage	of	the	relative	transparency	of	biological	tissue	to	
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near-infrared	light	(700-1000	nm)	and	the	wavelength	dependent	absorption	characteristics	of	hemoglobin,	which	varies	with	oxygenation.	As	well	as	changes	in	oxyhemoglobin	(HbO2)	and	deoxyhemoglobin	(HHb),	changes	in	the	sum	of	HbO2	and	HHb	can	be	calculated	as	a	surrogate	measure	of	CBV	during	autoregulatory	vasoreactivity.		Fluctuations	in	ICP	and	CBV	during	vasoreactive	responses	correlate	to	fluctuations	in	the	NIRS	relative	total	tissue	hemoglobin.50	While	absolute	quantitative	measurements	of	CBF	and	CBV	can	be	made,	they	rely	on	manipulation	of	FiO2	or	injection	of	an	optical	tracer	and	provide	only	a	static	measurement.71	The	difference	between	oxygenated	hemoglobin	and	deoxyhemoglobin	(HbD)	has	also	been	shown	to	reflect	changes	in	CBF.72,73	More	recently,	NIRS-based	metrics	including	oxyhemoglobin	optical	density	have	been	used	to	estimate	CBF.74	The	regional	oxyhemoglobin	saturation	(rSO2)	is	primarily	a	venous-weighted	signal	and	reflects	the	hemoglobin	bound	oxygen	that	remains	after	tissues	have	taken	what	they	need.	In	other	words,	rSO2	demonstrates	changes	in	oxygen	supply	and	demand	and	thus	is	affected	by	factors	independent	of	pressure	autoregulation,	including	hemoglobin	level,	inspired	oxygen,	seizures,	sedation	and	temperature.	rSO2	may	be	a	better	surrogate	of	CBF	in	the	premature	infant	because	of	the	low	and	constant	cerebral	metabolic	rate	of	oxygen	in	this	population.	
	
Calculating	vasoreactivity	indices:	slow	wave	pressure	monitoring	
	 Pressure	autoregulation	monitoring	can	identify	the	optimal	ABP	with	most	robust	vasoreactivity	in	individual	patients	after	pediatric	and	adult	traumatic	brain	injury,	during	cardiopulmonary	bypass,	after	pediatric	cardiac	arrest	and	in	neonatal	HIE.75-77	The	ability	to	accurately	monitor	pressure	autoregulation	depends	on	analyzing	spontaneous	and	repetitive	slow	CBV	and	ICP	waves.	Lundgren	first	categorized	these	slow	waves	as	“B	waves”	which	occur	with	a	period	between	20	and	200	seconds.78	
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These	slow	waves	are	generated	from	the	cerebral	autoregulatory	vasodilation	and	vasoconstriction	that	occur	with	fluctuations	in	CPP.	As	the	vessels	dilate,	the	CBV	increases	and	the	ICP	correspondingly	increases.		When	the	vessels	constrict,	the	CBV	decreases	and	the	ICP	decreases.	Autoregulatory	vasoreactivity	can	then	be	measured	by	synchronously	measuring	ABP	at	the	same	frequency	to	analyze	the	relationship	between	the	ABP	and	intracranial	waveforms.	
Multiple	mathematical	algorithms	have	been	used	to	describe	the	relationship	between	ABP	and	CBV,	ICP	or	CBF	to	estimate	autoregulation.	These	include	simple	correlation,	and	in	the	frequency	domain,	cross-correlation	functions	of	coherence,	phase,	and	gain	have	all	been	used.	When	vasoreactivity	is	impaired,	CBF,	CBV	and	ICP	are	passive	to	ABP,	and	each	of	these	functions	quantifies	passivity	in	a	different	way.	The	interchangeability	of	these	myriad	metrics	is	not	known	and	this	proliferation	of	methods	with	minimal	validation	is	a	major	limitation	of	the	current	literature	of	autoregulation.	From	controlled	animal	models	with	known	states	of	intact	and	impaired	autoregulation,	it	has	been	shown	that	fluctuations	in	ABP	cause	coherent	and	in-phase	fluctuations	in	CBV	and	ICP	when	autoregulation	is	absent.	This	is	equivalent	to	a	positive	correlation.	When	autoregulatory	vasoreactivity	is	functional,	CBV	is	pressure-reactive	and	the	CBV	and	ICP	waveforms	are	coherent	with	ABP	but	have	a	180°	phase	shift.	This	is	equivalent	to	a	negative	correlation.	(Figure	3)	
Continuous	measurement	of	correlation	between	ABP	and	CBV	or	ICP	can	identify	the	optimal	ABP	with	most	functional	vasoreactivity.	The	optimal	ABP	found	at	the	nadir	of	the	plot	with	correlation	coefficients	on	the	y-axis	and	ABP	on	the	x-axis.	(Figure	4)	A	criticism	of	this	technique	is	that	optimal	ABP	is	not	identifiable	in	patients	without	a	U-shaped	curve	and	apparent	nadir.	Maintaining	blood	pressure	within	optimal	ABP	is	associated	with	less	brain	injury	on	MRI	and	improved	2-year	neurodevelopmental	outcomes	in	neonatal	HIE.79-83	Traumatic	brain	injury	and	preterm	neonate	studies	also	support	using	optimal	MAP	as	a	hemodynamic	goal.	
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Spontaneous	slow	wave	activity	can	have	variable	periodicity	and	amplitude	which	generates	imprecision	in	autoregulation	monitoring.	In	order	to	minimize	this	effect,	filters	can	be	applied	to	the	data	to	eliminate	time	epochs	with	inadequate	slow	wave	power	and	multiple	measurements	at	the	same	ABP	are	commonly	averaged	together	to	mitigate	noise	in	the	measurements.	This	important	limitation	of	continuous	autoregulation	monitoring	is	the	subject	of	ongoing	studies	using	advanced	signal	processing	techniques.	Limiting	noise	from	this	effect	would	result	in	a	faster	and	more	reliable	determinant	of	optimal	ABP	for	autoregulation.	
	
Methods	to	measure	neonatal	autoregulation	
The	above	concepts	have	been	applied	to	near-infrared	measurements	of	HbD	or	rSO2	to	estimate	CBF	autoregulation	in	neonates.	Although	slow	waves	of	ABP	are	erratic	and	introduce	noise	in	autoregulation	measurements,	they	occur	naturally	and	are	therefore	the	safest	way	to	measure	autoregulation.84	In	contrast,	traditional	autoregulation	monitoring	techniques	that	intentionally	change	the	ABP	with	thigh	cuff	deflation,	or	vasoconstrictor	injections	are	not	generally	suitable	for	critically	ill	neonates.85	
Time-domain	analysis	(correlation)	has	been	used	with	filters	to	limit	the	analysis	to	the	specific	frequency	range	of	slow	waves.	This	method	detected	the	LLA	with	high	sensitivity	and	specificity	in	animal	models.50,54,55,74	Maintaining	the	blood	pressure	within	the	optimal	ABP	from	this	method	is	associated	with	survival	and	neurologic	recovery	in	large	adult	studies	of	traumatic	brain	injury	50,75,86,87	and	in	single-center	studies	of	neonatal	HIE,	pediatric	cardiac	arrest,	and	pediatric	traumatic	brain	injury.79-81,83,88,89	Blood	pressure	deviation	from	optimal	ABP	delineated	in	this	way	may	also	be	associated	with	cardiopulmonary	and	renal	injury	in	neonatal	HIE	and	renal	injury	after	
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cardiopulmonary	bypass.32-34		
Frequency-domain	analyses	including	coherence,	phase,	and	gain	of		transfer	function	have	also	been	used	to	assess	autoregulation	in	the	preterm	neonate.84	These	analyses	include	assumptions	of	linearity	and	stationarity	that	are	not	always	present	in	biologic	systems.90	Limited	animal	data	have	validated	these	frequency	domain	cross-correlation	functions	for	estimating	cerebral	autoregulation.91	Coherence	and	gain	analyses	of	HbD	and	mean	ABP	identified	an	association	between	dysfunctional	autoregulation	and	brain	injury	on	MRI	or	death	in	neonatal	HIE.73	Limitations	include	low	precision	that	make	monitoring	for	several	hours	essential	to	reliably	measure	coherence.	In	some	studies	coherence	is	found	to	be	high	when	blood	pressure	is	either	above	or	below	the	LLA,	and	we	suggest	that	coherence	may	be	most	useful	as	a	filter	to	delineate	adequate	slow	wave	power	to	measure	autoregulation	with	either	phase	or	correlation.		
Wavelet	coherence	analysis	characterizes	continuous	or	intermittent	cross-correlations	between	two	time	series	at	multiple	time	scales,	which	makes	no	assumption	about	the	stationarity	of	input	signals.	This	technique	has	been	performed	in	limited	studies	especially	in	preterm	infants,	and	it	can	detect	frequencies	up	to	0.017	Hz	due	to	limitations	of	instruments	and	not	by	the	analysis	itself.92	Wavelet	coherence	analysis	of	ABP	and	cerebral	oximetry	at	ultra-low	frequencies	<0.0002	Hz	(80	min	time	scale)	has	been	associated	with	neurologic	outcome	in	HIE.93		
Finally,	an	alternative	assessment	of	autoregulation	uses	the	relationship	between	heart	rate	changes	and	cerebral	oxygenation.	The	tissue	oxygenation	heart	rate	reactivity	index	(TOHRx),	an	index	of	cerebral	vascular	reactivity,	is	derived	from	the	correlation	coefficient	between	slow	waves	of	heart	rate	(HR)	and	tissue	oxygenation	index	(TOI)	measured	with	NIRS.94	Higher	TOHRx	values	were	observed	in	infants	with	worse	clinical	score	of	mortality	and	morbidity	(Clinical	Risk	Index	for	Babies	II).	
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In	addition,	increased	passivity	between	TOI	and	HR	was	observed	with	arterial	hypotension.	These	TOHRx	findings	are	unique	to	the	preterm	population	and	may	be	related	to	systemic	hemodynamic	control	as	cardiac	output	in	preterm	infants	is	mainly	regulated	by	heart	rate	due	to	the	immature	myocardium.	In	adults,	CBF	has	no	correlation	with	output,	however,	in	preterm	infants	a	positive	correlation	between	CBF	and	left	cardiac	output	has	been	described.95,96	Further,	in	preterm	infants,	optimal	mean	arterial	blood	pressure	has	been	defined	using	TOHRx	in	a	cohort	of	infants	born	at	≤	32	weeks	gestational	age.	Absolute	deviations	away	from	optimal	blood	pressure	were	higher	in	those	infants	who	died.	Infants	who	developed	severe	IVH	had	deviations	away	from	optimal	values	greater	than	4	mmHg.	97	
	
Limitation	of	NIRS-based	autoregulation	monitoring	
	 There	are	limitations	of	NIRS	autoregulation	monitoring.	NIRS	placed	on	the	forehead	or	tempero-parietal	region	of	the	head	measures	the	frontal	lobe	and	tempero-parietal	lobes	and	cannot	capture	vasoreactivity	in	other	areas	known	to	be	vulnerable	in	HIE	and	prematurity,	including	many	white	matter	regions	(such	as	periventricular	white	matter),	basal	ganglia,	thalamus,	and	other	cortical	regions.	Thus,	frontal	optimal	ABP	may	not	reflect	that	of	other	anatomic	regions.	Autoregulation	has	a	prominent	macrocirculatory	component	from	involvement	of	large	cerebral	arteries	and	pial	arterioles	that	are	upstream	from	local	parenchymal	tissue.	Autoregulatory	vasoreactivity	is	primarily	mediated	by	intrinsic	myogenic	responses	to	changes	in	transmural	pressure.	Global	cerebral	ischemia	in	HIE	and	vascular	immaturity	in	preterm	neonates	would	not	be	expected	to	cause	large	regional	differences	in	optimal	ABP.	It	is	also	likely	that	prolonged	and	large	deviations	in	blood	pressure	from	optimal	MAP	in	frontal	or	tempero-parietal	cortex	will	affect	perfusion	throughout	much	of	the	brain.	In	the	absence	of	clinically	
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available	autoregulation	metrics	for	regional	autoregulatory	function,	identifying	optimal	MAP	in	the	frontal	lobe	is	a	reasonable	first	approximation	to	guide	hemodynamic	management	in	critically	ill	neonates.	NIRS	also	permits	continuous	monitoring	over	long	periods	of	time	that	cannot	be	easily	accomplished	with	transcranial	Doppler.	
	
NIRS	autoregulation	monitoring	in	specific	neonatal	diseases	
The	purpose	of	this	review	of	relevant	studies	was	to	examine	those	studies	that	were	associated	with	specific	outcome	measures.	The	studies	presented	were	found	through	PubMed	search	using	“prematurity”	or	“premature”	or	“neonate”	and	“hypoxic	ischemic	encephalopathy”	or	“neonatal	encephalopathy”	with	“autoregulation”	and	“cerebral	blood	flow.”	Studies	were	then	selected	that	focused	on	time	and	frequency	domain	or	wavelet	autoregulation	methodologies	using	NIRS	in	this	population.	
	
Prematurity/Intraventricular	Hemorrhage	
Both	time	domain	and	frequency	domain	analyses	have	been	used	to	measure	autoregulation	in	premature	infants.	CBF	autoregulation	to	systolic	and	mean	ABP	develops	between	23	and	33	weeks	gestation,	and	infants	younger	than	26	weeks	GA	are	at	high	risk	of	pressure-passive	CBF.	However,	CBF	is	overall	passive	to	diastolic	ABP	before	33	weeks’	gestation.2	Dysfunctional	autoregulation	is	common	in	premature	infants	with	many	demonstrating	fluctuating	pressure	passivity	over	the	first	few	days	of	life.98	In	addition,	impairments	in	autoregulation	increase	the	risk	of	severe	intraventricular	hemorrhage	and	death	and	those	infants	with	IVH	often	have	cerebral	hyperperfusion	and	pressure	passive	cerebral	perfusion	with	correlation	of	rSO2	and	ABP.99-103	Further,	sic
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dysautoregulation	and	have	a	potentially	narrower	autoregulatory	plateau	meaning	those	infants	may	be	more	sensitive	to	fluctuations	in	ABP.104	This	is	in	agreement	with	our	findings	that	CBF	autoregulation	to	systolic	and	mean	ABP	develops	between	23	and	33	weeks	gestation,	and	infants	younger	than	26	weeks	GA	are	at	high	risk	of	pressure-passive	CBF.	Dopamine	therapy	was	associated	with	dysfunctional	autoregulation,	but	it	is	unclear	whether	dopamine	impaired	autoregulation	or	if	it	was	an	indicator	of	severe	illness.105	Finally,	blood	pressure	divergence	below	optimal	ABP	was	associated	with	death,	and	deviation	above	optimal	ABP	increased	the	risk	of	severe	intraventricular	hemorrhage.97	 	
	
HIE	
Frequency,	time,	and	wavelet	coherence	analyses	have	been	used	to	study	HIE	during	spontaneous	blood	pressure	fluctuations.		Poorer	autoregulatory	function	measured	by	coherence	and	gain	between	HbD	and	ABP	were	associated	with	brain	injury	on	MRI	or	death.73	Blood	pressure	deviation	from	optimal	ABP	identified	by	time	domain	analysis	was	associated	with	greater	brain	injury	on	MRI	and	worse	2-year	neurodevelopmental	outcomes.79-83	Finally,	in-phase	coherence	of	mean	ABP	and	cerebral	oximetry	at	time	scales	less	than	80	min	(<	0.0002	Hz)	and	anti-phase	coherence	at	time	scales	of	approximately	2.5	h	(~	0.0001	Hz)	were	reported	by	wavelet	coherence	analysis.	Both	in-phase	and	anti-phase	coherence	were	related	to	worse	clinical	outcomes.93		
	 	
Neonatal	cardiac	disease	and	cardiopulmonary	bypass	
	 Autoregulation	monitoring	in	neonates	with	congenital	cardiac	disease	has	been	conducted	in	both	the	frequency	and	time	domains.	Hypercarbia	and	fluctuations	in	ABP	were	associated	with	dysfunctional	autoregulation	after	cardiac	surgery.106	Autoregulatory	function	worsens	at	lower	blood	
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pressures	during	cardiopulmonary	bypass,	and	the	LLA	can	be	identified	in	nearly	80%	of	patients	during	bypass.107	Hypothermia	was	thought	to	cause	impaired	autoregulation	in	this	population,	but	further	study	demonstrated	that	neonates	are	managed	with	lower	ABP	during	hypothermia,	and	the	effect	of	hypothermia	cannot	be	isolated	in	these	data.108	Finally,	term	newborns	with	congenital	heart	disease	displayed	associations	between	abnormal	cerebral	autoregulation	and	greater	fractional	tissue	oxygen	extraction,	lack	of	sedation,	and	lower	hemoglobin	suggesting	that	impaired	oxygen	delivery	and	increased	cerebral	metabolic	demand	may	overwhelm	autoregulatory	capacity	in	these	infants.109		
Extracorporeal	Membrane	Oxygenation	(ECMO)	
	 Wavelet	cross	correlation	was	calculated	between	mean	ABP	and	NIRS	oxyhemoglobin	saturation	in	neonates	receiving	veno-arterial	ECMO.	NIRS	signals	were	measured	in	the	frontal,	parietal	and	occipital	cortices	using	multi-modal	NIRS	monitoring	and	a	customized	head	cap.	Decreasing	the	ECMO	flow	from	100%	to	70%	caused	dysfunctional	autoregulation	at	lower	flow.	Right	parietal	cortex	had	greater	disruptions	in	autoregulation	than	the	left	parietal	cortex,	which	may	be	related	to	right-sided	cannulation	of	the	common	carotid	artery	and	internal	jugular	vein.110	Obstructions	in	cephalic	venous	drainage	may	affect	autoregulation	by	increasing	the	ICP.51	Further	studies	are	needed	on	the	effects	of	carotid	and	jugular	ECMO	cannulae	on	cerebrovascular	hemodynamics.		
	
Future	Directions	
The	majority	of	neonatal	autoregulation	and	vasoreactivity	studies	are	limited	to	small	and	often	single-center	studies.	Multicenter	studies	are	needed	to	increase	sample	size,	account	for	variation	in	clinical	practice,	and	accommodate	the	challenges	of	enrolling	neonates,	a	medically	fragile	population,	in	
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clinical	studies.	Moreover,	autoregulation	monitoring	requires	an	indwelling	arterial	catheter	because	non-invasive	continuous	ABP	monitoring	techniques,	such	as	photoplethysmography,	have	not	been	well	established	in	neonates.	The	requirement	for	an	arterial	catheter	and	reluctance	of	some	families	to	enroll	their	critically	ill	infants	in	clinical	research	limits	sample	sizes.	If	large	scale	observational	data	support	a	link	between	functional	autoregulation	and	improved	neurologic	outcomes,	interventional	studies	to	determine	whether	identifying	and	targeting	optimal	ABP	should	be	considered.		Ancillary	studies	to	ongoing	neonatal	clinical	trials,	including	erythropoietin	and	other	adjuvant	therapies,	provide	additional	opportunities	to	test	the	effect	of	drug	therapies	on	cerebral	autoregulation.	
Neonatal	animal	models	could	define	the	utility	and	limitations	of	non-invasive,	regional	autoregulation	monitoring.	For	instance,	regional	variation	in	thalamic	and	cortical	CBF	after	hypoxia	in	developing	brain	could	be	compared	to	clinically	accessible	NIRS	and	middle	or	anterior	cerebral	artery	transcranial	Doppler.111	This	would	require	a	large	animal	model	that	permits	synchronized,	multi-modal,	cerebral	measurements,	such	as	piglets.	Optimal	ABP	in	discrete	anatomic	regions,	including	basal	ganglia,	thalamus,	large	white	matter	tracts,	and	different	cortices	could	be	identified	with	laser	Doppler	flowmetry	and	local	brain	tissue	oxygenation	through	correlation	with	ABP.	Then,	regional	optimal	ABP	could	be	compared	to	that	of	frontal	cortex	over	long	monitoring	periods	to	extrapolate	information	on	clinical	frontal	NIRS	autoregulation	monitoring.		
The	ultimate	goal	of	supporting	autoregulation	is	to	improve	neurologic	outcomes,	and	this	can	only	be	accomplished	by	preventing	neural	cell	death.	Animal	models	can	help	determine	whether	functional	vasoreactivity	blocks	neuropathologic	processes	after	hypoxia	and	reperfusion.	These	pathways	include	oxidative	and	endoplasmic	reticulum	stress,	inflammation,	disruptions	in	proteostasis	and	synaptogenesis,	and	activation	of	cell	death	pathways	in	white	and	gray	matter.	Premature	swine	and	ovine	models	could	also	be	used	to	test	interventions	aimed	at	supporting	autoregulation.112,113		
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Conclusion	
	 Current	clinical	practice	does	not	prevent	neurologic	injuries	in	critically	ill	neonates,	and	generalized	blood	pressure	guidelines	are	inadequate.	Cerebrovascular	autoregulation	and	vasoreactivity	monitoring	can	define	the	blood	pressure	range	that	best	supports	CBF	to	the	developing	brain.	In	particular,	neonates	affected	by	prematurity,	hypoxia-ischemia,	congenital	heart	disease	or	infants	requiring	ECMO	may	benefit	from	autoregulation-directed	care.	Precision	medicine	applied	to	autoregulation	and	vasoreactivity	monitoring	can	individualize	neuroprotective	treatments	in	critically	ill	neonates.
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Figure	Legend	
Figure	1.	Cerebral	blood	flow	autoregulation	curve	
Autoregulation	is	the	physiologic	mechanism	that	holds	blood	flow	to	the	brain	constant	across	a	range	of	blood	pressure.	The	flat	area	of	the	curve	is	a	state	of	pressure	reactivity	where	blood	pressure	and	blood	flow	go	in	opposite	directions.	However,	outside	the	range	of	autoregulation	on	the	two	ends	is	a	state	of	pressure	passivity	where	blood	flow	is	purely	dependent	on	blood	pressure.	There	is	no	more	reactivity	in	the	vessels.			
	
Figure	2.	Changes	in	critical	closing	pressure	across	gestational	age			Critical	closing	pressure	increases	with	gestational	age	at	a	rate	of	1.4	mm	Hg	per	week	of	gestation	(P	<	
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0.0001).		From	Rhee	CJ	et	al.	Pediatr	Res.	2015;78(1):71-5.	
	
Figure	3.	Graphical	explanations	of	the	autoregulation	metrics.		
(A)	Coherence	analysis	of	CBF	measured	by	transcranial	Doppler	(TCD)	ultrasound	in	preterm	neonate.	Coherence	is	high	between	ABP	(red	line)	and	CBF	(black	line)	indicating	a	state	of	dysautoregulation	at	slow	wave	frequencies.	Bottom	panel	shows	coherence	as	a	function	of	frequency.	(B)	Waveform	1	(W1,	solid	line)	and	waveform	2	(W2,	dotted	line)	are	shown	for	concept.	The	gain	is	the	damping	effect,	and	the	phase	shift	is	the	time	delay	between	the	two	waveforms.	Lower	gain	indicates	better	autoregulatory	function.	(C,	D)	Blood	pressure	was	decreased	in	a	neonatal	piglet	with	continuous	mean	arterial	blood	pressure	(MAP),	intracranial	pressure	(ICP),	cerebral	blood	volume	(CBV)	NIRS	tissue	hemoblobin	index,	and	cerebral	blood	flow	(CBF)	laser	Doppler	flow	(LDF)	measurements.		When	MAP	exceeds	the	lower	limit	of	autoregulation	and	CBF	is	relatively	constant,	slow	MAP	waves	are	out	of	phase	with	the	ICP	and	CBV	(red	star	and	box).	As	MAP	decreases	below	the	lower	limit	of	autoregulation	and	CBF	falls,	the	MAP,	ICP	and	CBV	waves	are	all	in	phase	indicating	a	state	of	dysautoregulation	(blue	cross	and	box).		Adapted	with	permission	from:	
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Figure	4.	Determining	optimal	arterial	blood	pressure	
An	example	of	one	patient	using	autoregulation	monitoring	to	determine	optimal	mean	arterial	blood	pressure	(MAP).	Slow	waves	of	MAP	(top)	and	cerebral	blood	volume	(CBV,	bottom)	are	depicted	(A/C).	Autoregulation	monitoring	during	periods	of	intact	and	impaired	autoregulation	in	this	infant.	When	autoregulation	is	intact,	MAP	waves	negatively	correlate	to	changes	in	NIRS-measured	CBV	(A/B).	The	correlation	of	CBV	and	MAP	is	the	hemoglobin	volume	index	(HVx).	When	autoregulation	is	impaired,	MAP	and	CBV	become	positively	correlated,	yielding	a	positive	HVx	(C/D).	Thus,	a	more	negative	HVx	indicates	functional	pressure	reactivity	and	intact	autoregulation,	and	a	more	positive	HVx	indicates	decreased	pressure	reactivity	and	impaired	autoregulation.	When	the	measures	of	HVx	are	then	plotted	as	a	function	of	MAP	and	placed	in	5	mm	Hg	bins,	optimal	MAP	is	identified	as	the	nadir	when	the	correlation	coefficients	are	plotted	against	ABP	(E).	Here	for	this	patient,	optimal	ABP	is	50	mm	Hg	where	autoregulation	is	intact	and	most	robust.		
	
